Related Experiment Video
Updated: Dec 11, 2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum
Ramesh M Bhat1, Tanvi P Vaidya1
1Department of Dermatology, Father Muller Medical College, Mangalore, Karnataka, India.
Abstract:
Erythema nodosum leprosum (ENL) is a manifestation of type II lepra reaction, seen in lepromatous or borderline lepromatous leprosy. Although it is a common reaction encountered in clinical practice, there are an increasingly large number of newer updates in the pathophysiology and management of this condition. The treatment options have expanded far beyond just thalidomide and steroids and now extends to TNF-α inhibitors, thalidomide analogs, tenidap, cyclosporine A, plasma exchange, and even IVIG amongst others. These updates and the current knowledge of ENL are summarized in this review.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Rheumatic Heart Disease IV: Nursing Management
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease III: Medical Management

